Compound Summary
Buformin
Compound Information
Buformin
Compound Name: | Buformin |
Compound CID: | 2468 |
Synonyms: | Buformin 1-Butylbiguanide Buformine Butylbiguanide Butyldiguanide More... |
Iupac Name: | 2-butyl-1-(diaminomethylidene)guanidine |
InChI: | InChI=1S/C6H15N5/c1-2-3-4-10-6(9)11-5(7)8/h2-4H2,1H3,(H6,7,8,9,10,11) |
InChIKey: | XSEUMFJMFFMCIU-UHFFFAOYSA-N |
Canonical Smiles: | CCCCN=C(N)N=C(N)N |
Isomeric Smiles: | CCCCN=C(N)N=C(N)N |
Molecular Weight: | 157.22 |
Molecular Formula: | C6H15N5 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
Buformin
Molecular Weight: | 157.22 |
Molecular Formula: | C6H15N5 |
Hydrogen Bond Donor Count: | 3 |
Hydrogen Bond Acceptor Count: | 1 |
Rotatable Bond Count: | 4 |
Heavy Atom Count: | 11 |
Complexity: | 156 |
Synonyms
Buformin
| Buformin | Buformin |
|---|---|
Buformin |
1-Butylbiguanide |
Buformine |
Butylbiguanide |
Butyldiguanide |
Butformin |
692-13-7 |
Butylbiguanidum |
Glybigid |
1-Butyldiguanide |
Adebit |
BIGUANIDE, 1-BUTYL- |
W 37 |
Imidodicarbonimidic diamide, N-butyl- |
Biforon |
Diabrin |
Panformin |
Sindiatil |
Andere |
UNII-W2115E9C7B |
N-butylimidodicarbonimidic diamide |
DBV hydrochloride |
H 224 |
Imidodicarbonimidicdiamide, N-butyl- |
Butyl guanylguanidine |
DBV |
CHEBI:3209 |
692-13-7 (free base) |
Glybigidum |
Butylbiguanide hydrochloride |
N-Butylbiguanide |
W2115E9C7B |
NCGC00164533-01 |
NCGC00164533-02 |
Buformine INN-French |
Buforminum INN-Latin |
DSSTox_CID_26420 |
DSSTox_RID_81598 |
Buformina INN-Spanish |
DSSTox_GSID_46420 |
Buforminum |
Buformina |
Buformin USAN:INN |
n-Butylbiguanidine |
CAS-692-13-7 |
NSC113665 |
SB 103 |
EINECS 211-726-4 |
BRN 0607037 |
Butylbiguanid |
N1-Butylbiguanide |
N,n-butylbiguanide |
1-n-butylbiguanide |
2-butyl-1-(diaminomethylene)guanidine |
2-butyl-1-(diaminomethylidene)guanidine |
Buformin (USAN/INN) |
SCHEMBL27451 |
4-04-00-00582 (Beilstein Handbook Reference) |
CHEMBL39736 |
DTXSID6046420 |
SCHEMBL15762988 |
1-butyl-3-carbamimidoyl-guanidine |
ALBB-023188 |
Biguanide, 1-butyl-, hydrochloride |
HY-B2099 |
ZINC4097425 |
Tox21_112164 |
N-Butyldicarbonimido/ic diamide/imido |
SBB056560 |
STL484281 |
AKOS003382834 |
AKOS006228752 |
Tox21_112164_1 |
DB04830 |
MCULE-5413481004 |
NCGC00186641-01 |
2-butyl-1-(diaminomethylidene)-guanidine |
ST088005 |
amino(butylamino)iminomethylcarboxamidine |
CS-0017529 |
C07674 |
D00595 |
96642-EP2287163A1 |
96642-EP2305678A1 |
179391-EP2275108A1 |
Q715104 |
SR-01000944701 |
((1E)-1-amino-2-azahex-1-enyl)aminocarboxamidine |
Imidodicarbonimidic diamide, N-butyl-, hydrochloride |
SR-01000944701-1 |
Experimental Data
Buformin
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rattus norvegicus | 687.000000000000000 | 737.000000000000000 | 7.300000000000000 | 1054.000000000000000 | 1112.000000000000000 | 5.500000000000000 | S | LIO | FEMALES | 21084729 | Active | ||
| Rattus norvegicus | 5.000000000000000 | mg | 687.000000000000000 | 737.000000000000000 | 7.300000000000000 | 1054.000000000000000 | 1113.000000000000000 | 5.500000000000000 | S | LIO | FEMALES | 14618027 | Active |
Experimental Data Visualization
Buformin
Statistics Data
Buformin
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Rattus norvegicus | 7.300000000000000 | 5.500000000000000 | 2 | 2 |
Statistics Data Visualization
Buformin
